Ficlatuzumab (Anti-HGF / SF)

Ficlatuzumab (Anti-HGF / SF) is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). It inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion and can be used to treat head and neck squamous cell carcinoma (HNSCC). MW :150 KD.
Supplier Selleck Chemicals
Product # A2661
Sku # A2661-1mg
Pricing 1mg, $370.00
Feedback